47 related articles for article (PubMed ID: 29139064)
1. Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.
Hill RM; Kuijper S; Lindsey JC; Petrie K; Schwalbe EC; Barker K; Boult JK; Williamson D; Ahmad Z; Hallsworth A; Ryan SL; Poon E; Robinson SP; Ruddle R; Raynaud FI; Howell L; Kwok C; Joshi A; Nicholson SL; Crosier S; Ellison DW; Wharton SB; Robson K; Michalski A; Hargrave D; Jacques TS; Pizer B; Bailey S; Swartling FJ; Weiss WA; Chesler L; Clifford SC
Cancer Cell; 2015 Jan; 27(1):72-84. PubMed ID: 25533335
[TBL] [Abstract][Full Text] [Related]
2. Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma.
Ahmad Z; Jasnos L; Gil V; Howell L; Hallsworth A; Petrie K; Sawado T; Chesler L
PLoS One; 2015; 10(3):e0119834. PubMed ID: 25785590
[TBL] [Abstract][Full Text] [Related]
3. Role of MYC in Medulloblastoma.
Roussel MF; Robinson GW
Cold Spring Harb Perspect Med; 2013 Nov; 3(11):. PubMed ID: 24186490
[TBL] [Abstract][Full Text] [Related]
4. Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.
Kawauchi D; Ogg RJ; Liu L; Shih DJH; Finkelstein D; Murphy BL; Rehg JE; Korshunov A; Calabrese C; Zindy F; Phoenix T; Kawaguchi Y; Gronych J; Gilbertson RJ; Lichter P; Gajjar A; Kool M; Northcott PA; Pfister SM; Roussel MF
Oncogene; 2017 Sep; 36(37):5231-5242. PubMed ID: 28504719
[TBL] [Abstract][Full Text] [Related]
5. ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.
Mainwaring OJ; Weishaupt H; Zhao M; Rosén G; Borgenvik A; Breinschmid L; Verbaan AD; Richardson S; Thompson D; Clifford SC; Hill RM; Annusver K; Sundström A; Holmberg KO; Kasper M; Hutter S; Swartling FJ
Nat Commun; 2023 Mar; 14(1):1221. PubMed ID: 36869047
[TBL] [Abstract][Full Text] [Related]
6. HDACs and MYC in medulloblastoma: how do HDAC inhibitors control MYC-amplified tumors?
Shofuda T; Kanemura Y
Neuro Oncol; 2021 Feb; 23(2):173-174. PubMed ID: 33394043
[No Abstract] [Full Text] [Related]
7. A genome-wide association study on medulloblastoma.
Dahlin AM; Wibom C; Andersson U; Bybjerg-Grauholm J; Deltour I; Hougaard DM; Scheurer ME; Lau CC; McKean-Cowdin R; Kennedy RJ; Hung LT; Yee J; Margol AS; Barrington-Trimis J; Gauderman WJ; Feychting M; Schüz J; Röösli M; Kjaerheim K; ; Januszkiewicz-Lewandowska D; Fichna M; Nowak J; Searles Nielsen S; Asgharzadeh S; Mirabello L; Hjalmars U; Melin B
J Neurooncol; 2020 Apr; 147(2):309-315. PubMed ID: 32056145
[TBL] [Abstract][Full Text] [Related]
8. Breaking down the barrier to medulloblastoma treatment: Piezo2 knockout disrupts the BTB and increases vascular permeability.
Sprowls SA; Lathia JD
Neuron; 2023 Jan; 111(1):3-5. PubMed ID: 36603549
[TBL] [Abstract][Full Text] [Related]
9. WNT-activated, MYC-amplified medulloblastoma displaying intratumoural heterogeneity.
Green S; Hoover T; Doss D; Davidow K; Walter AW; Cottrell CE; Mahapatra S
Neuropathol Appl Neurobiol; 2024 Feb; 50(1):e12945. PubMed ID: 38093348
[No Abstract] [Full Text] [Related]
10. Deriving a continuum score for group 3 and 4 medulloblastoma tumor samples analyzed via RNA-sequencing or DNA methylation microarray.
Hacking JPR; Thompson D; Schwalbe EC; Clifford SC; Williamson D
STAR Protoc; 2023 Sep; 4(3):102509. PubMed ID: 37573504
[TBL] [Abstract][Full Text] [Related]
11. Defining the Role of Extrachromosomal DNA Amplifications in Medulloblastoma.
Zhao D; Verhaak RGW
Cancer Res; 2024 Feb; 84(4):515-516. PubMed ID: 38175761
[TBL] [Abstract][Full Text] [Related]
12. Actions speak louder than ORFs: A non-canonical microprotein promotes medulloblastoma oncogenesis.
Delaidelli A; Oliveira de Santis J; Sorensen PH
Mol Cell; 2024 Jan; 84(2):188-190. PubMed ID: 38242097
[TBL] [Abstract][Full Text] [Related]
13. De-coding Group 3 medulloblastoma biology with noncoding RNA.
Diamandis P
Neuro Oncol; 2021 Apr; 23(4):525-526. PubMed ID: 33471897
[No Abstract] [Full Text] [Related]
14. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic Effects of NF-κB Inhibition by DHMEQ (Dehydroxymethylepoxyquinomicin) Alone and in Co-treatment with Radio-and Chemotherapy in Medulloblastoma Cell Lines.
Ramos PMM; Pezuk JA; Castro-Gamero AM; Oliveira HF; Scrideli CA; Umezawa K; Tone LG
Anticancer Agents Med Chem; 2018; 18(4):541-549. PubMed ID: 29141555
[TBL] [Abstract][Full Text] [Related]
16. TP53 Mutation, MYCN Amplification, and Large Cell/Anaplastic Histology in Medulloblastoma.
Das A; Zameer L; Vinarkar S; Singh M; Parihar M; Arora N; Chandra A; Achari RB
Indian J Pediatr; 2018 Aug; 85(8):684-685. PubMed ID: 29139064
[No Abstract] [Full Text] [Related]
17. Clinical Aggressiveness of TP53-Wild Type Sonic Hedgehog Medulloblastoma With MYCN Amplification, Chromosome 17p Loss, and Chromothripsis.
Mitani Y; Fukuoka K; Mori M; Arakawa Y; Matsushita Y; Hibiya Y; Honda S; Kobayashi M; Tanami Y; Kanemura Y; Ichimura K; Nakazawa A; Kurihara J; Koh K
J Neuropathol Exp Neurol; 2021 Jan; 80(2):205-207. PubMed ID: 33367701
[No Abstract] [Full Text] [Related]
18. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
Pfaff E; Remke M; Sturm D; Benner A; Witt H; Milde T; von Bueren AO; Wittmann A; Schöttler A; Jorch N; Graf N; Kulozik AE; Witt O; Scheurlen W; von Deimling A; Rutkowski S; Taylor MD; Tabori U; Lichter P; Korshunov A; Pfister SM
J Clin Oncol; 2010 Dec; 28(35):5188-96. PubMed ID: 21060032
[TBL] [Abstract][Full Text] [Related]
19. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
